760 filings
Page 28 of 38
8-K
fmxl2b2ae45t2d2bz
2 Nov 12
Threshold Pharmaceuticals Reports Third Quarter 2012 Financial and Operational Results
12:00am
8-K
ncflh2ha
16 Oct 12
Other Events
12:00am
8-K
13xdd6iznm yv
2 Oct 12
Other Events
12:00am
8-K
pnlvy6u
17 Sep 12
Threshold Pharmaceuticals to Present Updated Data from Phase 2b
12:00am
CT ORDER
v0ukpz1pnc8 aq1qfwg
6 Aug 12
Confidential treatment order
12:00am
8-K
81a 469348kt
2 Aug 12
Threshold Pharmaceuticals Reports SECONd Quarter 2012 Financial AND OPERATIONAL Results
12:00am
8-K
6hmuamp58vl9f
5 Jun 12
Threshold Pharmaceuticals Announces Highlights of TH-302 Presentations at 2012 American Society of Clinical Oncology Annual Meeting
12:00am
8-K
tp73 xj53bx8j4kr8m
18 May 12
Submission of Matters to a Vote of Security Holders
12:00am
8-K
indfdf8l ki4l
4 May 12
Threshold Pharmaceuticals Reports FIRST Quarter 2012 Financial AND OPERATIONAL Results
12:00am
8-K
hvr19n
12 Apr 12
Threshold Pharmaceuticals Earns $20 million Milestone Payment from Merck KGaA for Positive Results from Phase 2 Trial of TH-302 in Pancreatic Cancer
12:00am
8-K
joh8x7r9
12 Apr 12
Entry into a Material Definitive Agreement
12:00am
8-K
tibk7mp0
30 Mar 12
Other Events
12:00am
424B3
61jv 4ishr
29 Mar 12
Prospectus supplement
12:00am
8-K
8yk0v
19 Mar 12
Threshold Pharmaceuticals' TH-302 Receives Orphan Drug Designation in the European Union for the Treatment of Soft Tissue Sarcoma
12:00am
S-8
3t5hq4y 5tzbsh
15 Mar 12
Registration of securities for employees
12:00am
8-K
jprr09 o0gy211pm3
14 Mar 12
Other Events
12:00am